buy

Halozyme Therapeutics Inc. buy Morgan Stanley

Halozyme Therapeutics Inc.

Start price

€57.80

/ 50%

Target price

20.10.26

Performance (%)

Price

Summary

This prediction is currently active. With a performance of , the BUY prediction for Halozyme Therapeutics Inc. by Morgan_Stanley is down slightly. This prediction currently runs until 20.10.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction

Performance without dividends (%)

Name	1w
Halozyme Therapeutics Inc.
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by Morgan_Stanley for this prediction

In the thread Halozyme Therapeutics Inc. diskutieren

Prediction Buy

Perf. (%)

Target price 67.750

Change

Ends at

Halozyme Therapeutics (NASDAQ:HALO) had its price target lowered by analysts at Morgan Stanley from $80.00 to $79.00. They now have an "overweight" rating on the stock.

Ratings data for HALO provided by MarketBeat

Morgan Stanley